🔗 Share this article

Treasury head Reeves has announced she is planning "focused action to tackle cost of living pressures" in the forthcoming financial statement.

During an interview with media outlets, she noted that lowering price rises is a shared task of both the administration and the Bank of England.

The UK's price growth is forecast to be the highest among the G7 industrialized countries this year and next.

Potential Energy Cost Measures

Reports indicate the administration could take action to lower utility costs, for instance by reducing the present 5% rate of value-added tax applied on energy.

Another possibility is to cut some of the policy costs presently added to bills.

Fiscal Constraints and Expert Predictions

The government will receive the next draft from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much room there is for such measures.

The view from most economists is that the Chancellor will have to introduce higher taxes or budget cuts in order to adhere to her voluntary fiscal targets.

Previously on Thursday, analysis suggested there was a £22 billion gap for the chancellor to resolve, which is at the more modest range of forecasts.

"There's a shared job between the central bank and the government to further reduce some of the causes of price increases," Reeves stated to reporters in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Commitments and Global Concerns

While much of the attention has been on likely tax increases, the chancellor said the most recent information from the fiscal watchdog had not changed her pledge to manifesto promises not to raise rates on income tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with rising geopolitical and trade issues for the Budget tax moves, probably to be directed on those "most able to pay."

International Trade Tensions

Addressing apprehensions about the United Kingdom's economic relations with the Asian nation she said: "Our security interests invariably take priority."

Last week's announcement by China to increase export controls on rare earths and other materials that are key for advanced tech manufacturing led US President the US President to propose an extra 100% import tax on imports from the Asian country, increasing the risk of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary called the Chinese move "economic coercion" and "a international production control attempt."

Questioned on considering the US offer to participate in its battle with the Asian nation, the Chancellor said she was "extremely troubled" by China's actions and encouraged the Chinese government "not to put up barriers and limit trade."

She said the decision was "damaging for the global economy and generates additional obstacles."

"In my view there are fields where we need to address China, but there are also valuable chances to export to Chinese markets, including financial services and other sectors of the economy. We've got to maintain that balance right."

The Treasury chief also stated she was collaborating with G7 counterparts "regarding our own essential resources plan, so that we are less reliant."

Health Service Medicine Pricing and Investment

Reeves also acknowledged that the price the National Health Service pays for drugs could increase as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in exchange for lower tariffs and capital.

Some of the biggest global drug companies have said lately that they are either pausing or scrapping operations in the UK, with some blaming the low prices they are obtaining.

Last month, the government science advisor said the cost the health service pays for drugs would need to rise to halt businesses and pharmaceutical investment departing from the UK.

Reeves told the BBC: "It has been observed because of the pricing regime, that clinical trials, new drugs have not been provided in the UK in the extent that they are in other EU nations."

"Our aim is to ensure that individuals getting treatment from the National Health Service are can obtain the best essential drugs in the globe. And so we are looking at this situation, and... looking to secure additional funding into the UK."